Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Jan 23, 2024 2:16pm
148 Views
Post# 35841333

RE:RE:RE:CAR-T update

RE:RE:RE:CAR-T update
The thought that Canadafan is sugguesting that onc could be taken private (or BO, partnership) is scarey as I was a shareholder in a company that was taken private and it only serves the purpose of whomever is taking it private and present managment and that is just a fact. As shareholders we need to make sure that this does not happen as it could be done with a low money raise and low sp (would be lucky to get 5 dollars per share). To me that is not an option no matter how they try to spin it as that in no way then creates shareholder value as shareholders are then left out in the cold.
We need either a partnership or BO and that should be the only options on the table.
We shall know soon enough as to what should be happening most likely before the AGM especially if they try to stick to their time table of a phase 3 mid 2024 and they need something big positive going into the AGM especially with all the voting that will be involved.
Things could get interesting or so we can all hope as that would be a nice change.
<< Previous
Bullboard Posts
Next >>